Citizen Portal
Sign In

Votes at a glance: Health Care & Wellness committee Feb. 25 actions

Health Care and Wellness Committee · February 25, 2026

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The committee reported seven bills out of committee with due‑pass recommendations on Feb. 25; vote tallies ranged from unanimous voice votes to contested roll calls. This roundup lists each bill, the committee action, and the announced roll‑call totals.

The Health Care and Wellness committee took final committee votes on seven bills on Feb. 25. Below are the items the committee reported out with the committee’s recommendation and the vote outcomes as announced by staff.

- ESHB 53‑95 (prior authorization): Reported out with a due‑pass recommendation. Announced tally: 16 ayes, 2 nays, 1 excused.

- SSB 59‑81 (340B reporting/fee framework): Reported out as amended with a due‑pass recommendation. Announced tally: 11 ayes, 7 nays, 1 excused.

- SSB 55‑94 (biosimilars): Reported out with a due‑pass recommendation (expedited voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.

- SSB 58‑77 (certified anesthesiology assistants / Physician Health Program): Reported out with a due‑pass recommendation (voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.

- SSB 61‑83 (coverage for all FDA‑approved HIV antivirals without utilization management): Reported out with a due‑pass recommendation (expedited voice vote). Announced tally: 18 ayes, 0 nays, 1 excused.

- SSB 62‑10 (health benefit exchange market factor criteria): Reported out as amended with a due‑pass recommendation. Announced tally: 11 ayes, 7 nays, 1 excused.

- SSB 6,226 (Board of Hearing and Speech; standards for hearing aids): Reported out as amended with a due‑pass recommendation. Announced tally: 17 ayes, 1 nay, 1 excused.

All items were reported out to the next legislative stage with the committee’s due‑pass recommendations. The committee adjourned at the conclusion of its business.